Article Details
Retrieved on: 2024-06-14 15:55:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LONDON - Mereo BioPharma Group plc (NASDAQ: MREO), a biopharmaceutical company specializing in rare diseases, has announced the pricing of its ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here